Sumitomo Chemical's final deficit was 312 billion yen, apparently. | 住友化学の最終赤字3120億円だったらしい。

連結子会社である住友ファーマの医薬品の特許権などで合計1808億円の減損を計上したそうなのですが最終赤字が3000億円以上になるのは恐ろしいですしこのまま赤字が増えていけばヤバそうな感じがしますね。しかし住友化学の会長は経団連の会長もしており消費税を上げるように言ってたりしていたからよそ見をしたせいでここまでの赤字転落をした可能性もありえますね。

https://www.nikkei.com/article/DGXZQOUC300QE0Q4A430C2000000/

The company has recorded a total of 180.8 billion yen in impairment losses on pharmaceutical patent rights of its consolidated subsidiary Sumitomo Pharma, but the final deficit of more than 300 billion yen is frightening, and if the deficit continues to increase, it looks like it will be in trouble. However, the chairman of Sumitomo Chemical is also the chairman of the Keidanren (Japan Business Federation), and he has been advocating a consumption tax hike, so it is possible that the deficit has fallen to this level because of his overestimation.